Variant report
Variant | rs12514996 |
---|---|
Chromosome Location | chr5:90515410-90515411 |
allele | A/C |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:90514200-90515800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr5:90514200-90515800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:90514200-90516600 | Enhancers | Hela-S3 | cervix |
4 | chr5:90514200-90517200 | Enhancers | Placenta Amnion | Placenta Amnion |
5 | chr5:90514400-90515600 | Enhancers | Fetal Intestine Large | intestine |
6 | chr5:90514400-90515800 | Enhancers | K562 | blood |
7 | chr5:90514400-90515800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
8 | chr5:90514400-90516000 | Enhancers | Primary B cells from cord blood | blood |
9 | chr5:90514400-90516000 | Enhancers | Adipose Nuclei | Adipose |
10 | chr5:90514400-90516200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr5:90514400-90516200 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr5:90514600-90515600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr5:90514800-90515600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr5:90514800-90515600 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
15 | chr5:90514800-90515600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr5:90514800-90515600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr5:90514800-90515600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
18 | chr5:90514800-90515600 | Flanking Active TSS | A549 | lung |
19 | chr5:90514800-90515600 | Enhancers | HMEC | breast |
20 | chr5:90514800-90515600 | Enhancers | NHLF | lung |
21 | chr5:90514800-90515800 | Enhancers | HSMMtube | muscle |
22 | chr5:90514800-90515800 | Flanking Active TSS | Osteobl | bone |
23 | chr5:90514800-90516400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
24 | chr5:90515000-90515600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
25 | chr5:90515000-90515800 | Enhancers | Stomach Mucosa | stomach |
26 | chr5:90515000-90515800 | Enhancers | NHDF-Ad | bronchial |
27 | chr5:90515000-90516000 | Enhancers | Primary monocytes fromperipheralblood | blood |
28 | chr5:90515000-90516000 | Enhancers | HSMM | muscle |
29 | chr5:90515200-90515800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
30 | chr5:90515200-90516000 | Enhancers | Brain Hippocampus Middle | brain |
31 | chr5:90515200-90516200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
32 | chr5:90515200-90516400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
33 | chr5:90515200-90519200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
34 | chr5:90515200-90519800 | Enhancers | Placenta | Placenta |
35 | chr5:90515400-90516000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |